We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anheuser-Busch Inbev (BUD) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
For the quarter ended June 2024, Anheuser-Busch Inbev (BUD - Free Report) reported revenue of $15.33 billion, up 1.4% over the same period last year. EPS came in at $0.90, compared to $0.72 in the year-ago quarter.
The reported revenue represents a surprise of +0.84% over the Zacks Consensus Estimate of $15.21 billion. With the consensus EPS estimate being $0.84, the EPS surprise was +7.14%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Anheuser-Busch Inbev performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Volume in Hectoliters - North America
: 22,369 KhL versus the four-analyst average estimate of 22,716.16 KhL.
Volume in Hectoliters - Middle America
: 38,381 KhL versus 38,302.86 KhL estimated by four analysts on average.
Volume in Hectoliters - South America
: 35,969 KhL versus 36,907.89 KhL estimated by four analysts on average.
AB InBev Worldwide - Total Volume
: 146,302 KhL compared to the 146,705.6 KhL average estimate based on four analysts.
Volume in Hectoliters - Asia Pacific
: 25,399 KhL compared to the 25,584.78 KhL average estimate based on four analysts.
Volume in Hectoliters - EMEA
: 23,852 KhL versus 23,114.11 KhL estimated by four analysts on average.
Revenue- South America
: $2.79 billion versus the four-analyst average estimate of $2.67 billion.
Revenue- Middle Americas
: $4.52 billion versus $4.35 billion estimated by four analysts on average.
Revenue- North America
: $3.86 billion versus the four-analyst average estimate of $3.87 billion.
Revenue- Asia Pacific
: $1.75 billion versus $1.84 billion estimated by four analysts on average.
Revenue- Europe
: $2.30 billion compared to the $2.29 billion average estimate based on four analysts.
Revenue- Global Export & Holding Companies
: $112 million versus $127.86 million estimated by two analysts on average.
Shares of Anheuser-Busch Inbev have returned -0.9% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Anheuser-Busch Inbev (BUD) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2024, Anheuser-Busch Inbev (BUD - Free Report) reported revenue of $15.33 billion, up 1.4% over the same period last year. EPS came in at $0.90, compared to $0.72 in the year-ago quarter.
The reported revenue represents a surprise of +0.84% over the Zacks Consensus Estimate of $15.21 billion. With the consensus EPS estimate being $0.84, the EPS surprise was +7.14%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Anheuser-Busch Inbev performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
View all Key Company Metrics for Anheuser-Busch Inbev here>>>Volume in Hectoliters - North America
: 22,369 KhL versus the four-analyst average estimate of 22,716.16 KhL.Volume in Hectoliters - Middle America
: 38,381 KhL versus 38,302.86 KhL estimated by four analysts on average.Volume in Hectoliters - South America
: 35,969 KhL versus 36,907.89 KhL estimated by four analysts on average.AB InBev Worldwide - Total Volume
: 146,302 KhL compared to the 146,705.6 KhL average estimate based on four analysts.Volume in Hectoliters - Asia Pacific
: 25,399 KhL compared to the 25,584.78 KhL average estimate based on four analysts.Volume in Hectoliters - EMEA
: 23,852 KhL versus 23,114.11 KhL estimated by four analysts on average.Revenue- South America
: $2.79 billion versus the four-analyst average estimate of $2.67 billion.Revenue- Middle Americas
: $4.52 billion versus $4.35 billion estimated by four analysts on average.Revenue- North America
: $3.86 billion versus the four-analyst average estimate of $3.87 billion.Revenue- Asia Pacific
: $1.75 billion versus $1.84 billion estimated by four analysts on average.Revenue- Europe
: $2.30 billion compared to the $2.29 billion average estimate based on four analysts.Revenue- Global Export & Holding Companies
: $112 million versus $127.86 million estimated by two analysts on average.Shares of Anheuser-Busch Inbev have returned -0.9% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.